Skip to main content
Displaying 1 - 12 of 13
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
The Growing Burden of MASLD/MASH: A Call to Action
Webcasts
View
Metabolism, Alcohol & Toxicity
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging D...
Webcasts
View
Metabolism, Alcohol & Toxicity
THR-β Agonists and Other Disease-specific Therapies Poised to Change the Paradigm
Webcasts
View
Metabolism, Alcohol & Toxicity
Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy
Webcasts
View
Metabolism, Alcohol & Toxicity
Clinical Case Challenge: Integrating MASLD/MASH-Specific Therapy into Practice
Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Wrap-up
Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients
Webcasts
View
Metabolism, Alcohol & Toxicity
Clinical cases presentation and discussion
Webcasts
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy